Remidio
PrivateLast Round
Grant
Jun 10, 2026
Est. Valuation
$67.5M
Total Funding Raised
$22.08M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Remidio is a medical technology company that develops and manufactures AI-powered portable ophthalmic imaging devices designed to help diagnose eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remidio Comparables
Compare Remidio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Forus Health | 90% | |
| Phelcom Technologies | 87% | |
| Oivi | 83% |
Remidio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 10, 2026 | ||||
| Corporate Funding | Feb 19, 2023 | ||||
| VC Round | Mar 31, 2022 | ||||
| Grant | Nov 18, 2020 | ||||
| VC Round | May 28, 2018 | ||||
Series B | Jan 15, 2016 |
Key People
Founding team and executive leadership
Remidio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IKP Knowledge Park | Seed |
| MedTech Innovator | Grant |
| Gates Foundation | Grant |
| Karnataka Information Technology Venture Fund | VC Round |
| Boundary Holding | VC Round |
| Cipher-Plexus Capital Advisors | Series B, Angel |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 66% MoM.
- Apr 1, 2026
Oculomics expands screening from eye to systemic diseases.
Remidio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Remidio's valuation, stock price, and market status.
Is Remidio a public or private company?
Remidio is a private company.
What is the current stock price of Remidio?
Remidio is a private company with no public stock price. No recent secondary market data is available.
How much is Remidio worth (valuation)?
Remidio's valuation is estimated at $66.6M based on funding round data.
Can I buy Remidio stock?
Remidio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Remidio's last funding round?
Remidio's most recent funding round was Series B on February 18, 2023.
Who are the main investors in Remidio?
Key investors in Remidio include Boundary Holding.
Will Remidio IPO soon?
No public IPO plans have been announced for Remidio.
How can I track Remidio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Remidio's secondary market activity and sign up for updates.